|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6711 USD | +0.16% |
|
-0.36% | +15.69% |
| Feb. 27 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Capitalization | 22.33M 19.13M 17.49M 16.56M 30.66M 2.13B 30.91M 209M 81.07M 1.01B 83.79M 82M 3.53B | P/E ratio 2026 * |
-1.14x | P/E ratio 2027 * | -1.05x |
|---|---|---|---|---|---|
| Enterprise value | 22.33M 19.13M 17.49M 16.56M 30.66M 2.13B 30.91M 209M 81.07M 1.01B 83.79M 82M 3.53B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: VYNE Therapeutics Inc.
| 1 day | +0.16% | ||
| 1 week | -0.36% | ||
| Current month | +5.40% | ||
| 1 month | +7.74% | ||
| 3 months | +13.09% | ||
| 6 months | +79.25% | ||
| Current year | +15.69% |
| 1 week | 0.64 |  | 0.68 |
| 1 month | 0.6 | | 0.69 |
| Current year | 0.55 | | 0.69 |
| 1 year | 0.28 | | 1.96 |
| 3 years | 0.28 | | 7.72 |
| 5 years | 0.28 | | 76.32 |
| 10 years | 0.28 | | 291.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Domzalski
CEO | Chief Executive Officer | 60 | 2020-02-29 |
Tyler Zeronda
DFI | Director of Finance/CFO | 40 | - |
Iain Stuart
CTO | Chief Tech/Sci/R&D Officer | 53 | 2020-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
David Domzalski
BRD | Director/Board Member | 60 | 2020-02-29 |
Sharon Barbari
BRD | Director/Board Member | 72 | 2020-02-29 |
Steven Basta
BRD | Director/Board Member | 61 | 2014-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -0.36% | -46.74% | -91.26% | 22.33M | |
| +1.02% | +0.84% | +42.05% | +87.52% | 50.04B | |
| -5.43% | -5.50% | +72.08% | +55.56% | 48.62B | |
| -1.78% | +10.66% | +77.10% | +502.98% | 25.57B | |
| -0.24% | -1.08% | -0.08% | -14.72% | 23.32B | |
| -3.60% | -1.03% | +40.99% | -29.12% | 17.89B | |
| -1.66% | -4.83% | +32.60% | -41.30% | 16.2B | |
| -2.75% | -7.27% | +53.03% | +190.95% | 14.97B | |
| -3.32% | +5.83% | -20.22% | +891.80% | 14.58B | |
| -3.89% | -5.40% | +38.03% | - | 13.47B | |
| Average | -2.13% | -2.39% | +28.89% | +172.49% | 22.47B | |
| Weighted average by Cap. | -2.19% | -2.92% | +43.84% | +162.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -50.25M -43.05M -39.36M -37.27M -69.01M -4.8B -69.57M -470M -182M -2.28B -189M -185M -7.95B | -66.25M -56.76M -51.89M -49.14M -90.98M -6.33B -91.72M -619M -241M -3.01B -249M -243M -10.48B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-14 | 0.6711 $ | +0.16% | 98,377 |
| 26-05-13 | 0.6700 $ | +1.53% | 278,218 |
| 26-05-12 | 0.6599 $ | -0.69% | 139,593 |
| 26-05-11 | 0.6645 $ | +0.59% | 124,052 |
| 26-05-08 | 0.6606 $ | -1.92% | 72,193 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VYNE Stock
Select your edition
All financial news and data tailored to specific country editions
